E Fund Management’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$539K Buy
+70,221
New +$481K 0.02% 280
2025
Q2
$74.2K Sell
28,108
-2,223
-7% -$5.98K ﹤0.01% 380
2025
Q1
$91.3K Sell
30,331
-8,569
-22% -$26K ﹤0.01% 386
2024
Q4
$99.6K Buy
38,900
+9,622
+33% +$40.1K 0.01% 378
2024
Q3
$109K Buy
29,278
+2,820
+11% +$13.1K 0.01% 339
2024
Q2
$167K Sell
26,458
-35,464
-57% -$234K 0.01% 300
2024
Q1
$333K Buy
61,922
+22,428
+57% +$102K 0.02% 263
2023
Q4
$198K Buy
+39,494
New +$124K 0.01% 286
2023
Q1
Sell
-24,706
Closed -$125K 344
2022
Q4
$125K Sell
24,706
-3,098
-11% -$17K 0.01% 321
2022
Q3
$138K Buy
+27,804
New +$127K 0.01% 320
2022
Q2
Sell
-22,816
Closed -$128K 336
2022
Q1
$128K Buy
22,816
+7,933
+53% +$48.7K ﹤0.01% 312
2021
Q4
$90K Buy
14,883
+2,245
+18% +$16.9K ﹤0.01% 289
2021
Q3
$123K Buy
+12,638
New +$139K 0.01% 254

Other funds holding IBRX